Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients with The study, which was 1 2 Thats particularly notable, they said, because one study of North American patients with RA found more than 3 They noted that patients with obesity are in a chronic proinflammatory state due to the overproduction of inflammatory cytokines and adipocytokines. 1 That heightened inflammation may in turn worsen RA symptoms and progression, the authors noted
Moreover, most longitudinal studies on this topic have been empirical, with a scant number of them providing quantitative analysis of the symptom progression
"One of the big problems with all of the medicines in this arena has been the cost
doi: 10.1007/s13197-019-04158-x 115 ZaniboniL.RizziR.CeroliniS
Allodynia is a widespread condition affecting large areas of the body, where normally non-painful stimuli like light touch or clothing contact produce pain
Availability and Access: Today vs